Skip to main content

Table 2 Correlation analysis between relapse compartment and survival time stratified according to secondary therapy; n = 87

From: Site of relapse of ductal adenocarcinoma of the pancreas affects survival after multimodal therapy

Recurrence/metastases

Total

Surgery

Chemotherapy

p-value

0.000

n

%

n

%

n

%

Hepatic

43

 

6

 

37

  

Local

28

 

11

 

17

  

Pulmonary

17

 

9

 

8

  

Relapse Chemotherapy/procedure

Hepatic, n

Local, n

Pulmonary, n

p-value

0.900

Gemcitabine

27

12

5

 

MD regime

10

5

3

 

FOLFIRINOX

–

–

–

 

BSC

–

–

–

 
  1. Fisher exact test was used to test for statistical significance. p-value ≤ 0.05 indicates significance
  2. BSC best supportive care, MD multi-drug
Back to article page

BMC Surgery

ISSN: 1471-2482

Contact us